Point72 Asia (Singapore) Pte. Ltd. Sera Prognostics, Inc. Transaction History
Point72 Asia (Singapore) Pte. Ltd.
- $646 Billion
- Q3 2025
A detailed history of Point72 Asia (Singapore) Pte. Ltd. transactions in Sera Prognostics, Inc. stock. As of the latest transaction made, Point72 Asia (Singapore) Pte. Ltd. holds 10,263 shares of SERA stock, worth $30,378. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,263
Previous 13,804
25.65%
Holding current value
$30,378
Previous $38.2 Million
17.87%
% of portfolio
0.0%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding SERA
# of Institutions
65Shares Held
21.9MCall Options Held
0Put Options Held
100-
Baker Bros. Advisors LP New York, NY5.5MShares$16.3 Million0.14% of portfolio
-
Whetstone Capital Advisors, LLC Shawnee Mission, KS3.63MShares$10.8 Million3.75% of portfolio
-
Interwest Venture Management CO2.42MShares$7.15 Million21.78% of portfolio
-
Abrdn PLC2.28MShares$6.75 Million0.01% of portfolio
-
Vivo Capital, LLC Palo Alto, CA1.65MShares$4.89 Million0.8% of portfolio
About SERA PROGNOSTICS, INC.
- Ticker SERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 29,596,900
- Market Cap $87.6M
- Description
- Sera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in asymptomatic singleton pregnancies. It is also developing a portfolio of product ...